What Initiates Inflammation in Acute Poststreptococcal Glomerulonephritis
What Initiates Inflammation in Acute Poststreptococcal Glomerulonephritis Acute poststreptococcal glomerulonephritis (APSGN) is an immune-mediated kidney disorder that often follows infections caused by certain strains of streptococcal bacteria. The core of its pathogenesis revolves around an intricate immune response that results in inflammation within the glomeruli—the tiny filtering units of the kidney. To understand what initiates inflammation in APSGN, it is essential to explore the sequence of immune events triggered by streptococcal infection.
The process begins with an infection, typically of the throat (pharyngitis) or skin (impetigo), caused by nephritogenic strains of group A beta-hemolytic streptococci. These bacteria produce specific antigens that are recognized by the immune system. In response, the body generates antibodies directed against these streptococcal antigens. However, in some cases, the immune response becomes dysregulated, leading to the formation of immune complexes—aggregates of bacterial antigens bound to host antibodies.
These immune complexes play a pivotal role in initiating glomerular inflammation. Once formed, they circulate in the bloodstream and tend to deposit in the glomeruli, particularly within the mesangial and subendothelial regions. The deposition of immune complexes is a critical event because it marks the beginning of the inflammatory cascade. These complexes act as foreign-like entities within the glomerulus, activating the complement system, especially the classical pathway.
Complement activation amplifies the inflammatory response by attracting immune cells such as neutrophils and macrophages to the site of deposition. These cells are recruited by chemotactic factors released during complement activation. Once recruited, they release a variety of inflammatory mediators—enzymes, reactive oxygen species, and cytokines—that cause damage to the glomerular basement membrane and the surrounding capillary walls. This damage results in increased permeability, allowing proteins and red blood cells to leak into the urine, which manifests as hematuria and proteinuria—the hallmark signs of APSGN.
Furthermore, the immune response involves cellular components such as T lymphocytes, which contribute to inflammation and tissue injury. The overall immune complex-mediated injury is a classic example of a Type III hypersensitivity reaction, where immune complexes deposit in tissues, inciting inflammation and tissue damage.
In summary, the initiation of inflammation in acute poststreptococcal glomerulonephritis is primarily driven by the formation and deposition of immune complexes in the glomeruli. These complexes activate the complement system, recruit inflammatory cells, and lead to tissue injury. This immune-mediated cascade underscores the importance of the host’s immune response in the pathogenesis of APSGN, illustrating how a normally protective mechanism can, under certain circumstances, result in tissue damage and clinical disease.
